Deutsche Bank: athenahealth Growth Story Back On Track (ATHN)

athenahealth ATHN reported solid 2Q earnings. Its EPS of $0.12 was above consensus of $0.10. The company also reported revenue of $58.6 million. Deutsche Bank had these takeaways: "1) Solid top-line (despite $1MM of revenue slippage). 2) Strong physician adds on both Collector and Clinicals, with 58% of new deals being 'double barrel' sales. 3) Rev. guidance for FY10 slightly below plan, but comes with visibility." athenahealth is currently rated Buy by Deutsche Bank. Deutsche Bank upped athenahealth's price target by $1 to $35.00. Shares of ATHN jumped 18.7% today and are currently trading at $26.19.